BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3841 related articles for article (PubMed ID: 24076059)

  • 21. Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.
    Yoon SR; Lee JH; Lee JH; Na GY; Lee KH; Lee YB; Jung GH; Kim OY
    Nutr J; 2015 Nov; 14():116. PubMed ID: 26530312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review.
    Fisher K; Hutcheon D; Ziegler J
    Nutr Clin Pract; 2020 Apr; 35(2):231-245. PubMed ID: 30937981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
    Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
    Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
    Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. History of the low FODMAP diet.
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():5-7. PubMed ID: 28244673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Irritable Bowel Syndrome: Physician-Dietitian Collaboration.
    Ireton-Jones C; Weisberg MF
    Nutr Clin Pract; 2020 Oct; 35(5):826-834. PubMed ID: 32786046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
    Staudacher HM; Ralph FSE; Irving PM; Whelan K; Lomer MCE
    J Acad Nutr Diet; 2020 Apr; 120(4):535-547. PubMed ID: 31029650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
    Erickson J; Korczak R; Wang Q; Slavin J
    Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The diet low in fermentable carbohydrates short chain and polyols improves symptoms in patients with functional gastrointestinal disorders in Spain].
    Huamán JW; Felip A; Guedea E; Jansana M; Videla S; Saperas E
    Gastroenterol Hepatol; 2015 Mar; 38(3):113-22. PubMed ID: 25458546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Insufficient evidence of the effect of the low FODMAP diet on irritable bowel syndrome].
    Krogsgaard LR; Lyngesen M; Bytzer P
    Ugeskr Laeger; 2015 Apr; 177(18):1503-7. PubMed ID: 25922242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
    Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study.
    Bellini M; Gambaccini D; Bazzichi L; Bassotti G; Mumolo MG; Fani B; Costa F; Ricchiuti A; De Bortoli N; Mosca M; Marchi S; Rossi A
    Tech Coloproctol; 2017 Jun; 21(6):451-459. PubMed ID: 28567692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of FODMAPs in irritable bowel syndrome.
    Shepherd SJ; Halmos E; Glance S
    Curr Opin Clin Nutr Metab Care; 2014 Nov; 17(6):605-9. PubMed ID: 25255126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fermentable Oligo-, Di-, and Mono-Saccharides and Polyols (FODMAPs) Consumption and Irritable Bowel Syndrome in the French NutriNet-Santé Cohort.
    Schneider E; Sabaté JM; Bouchoucha M; Hercberg S; Touvier M; Benamouzig R; Julia C; Buscail C
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to institute the low-FODMAP diet.
    Barrett JS
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():8-10. PubMed ID: 28244669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in the treatment of irritable bowel syndrome: indications and design.
    Zugasti Murillo A; Estremera Arévalo F; Petrina Jáuregui E
    Endocrinol Nutr; 2016 Mar; 63(3):132-8. PubMed ID: 26830853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable Bowel Syndrome and Diarrhea.
    Eswaran S; Chey WD; Jackson K; Pillai S; Chey SW; Han-Markey T
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1890-1899.e3. PubMed ID: 28668539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide, and Polyol Diet and Its Effects on Quality of Life in an Italian Cohort.
    Cingolani A; Paduano D; Vecchiarelli V; Demelas M; Corrias PT; Casula L; Usai P
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 193.